Skip to main content

STK 04: Thrombolytic Therapy

CBE ID
0437
1.4 Project
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

This measure captures the proportion of acute ischemic stroke patients who arrive at this hospital within 2 hours of time last known well for whom IV t-PA was initiated at this hospital within 3 hours of time last known well.

This measure is a part of a set of eight nationally implemented measures that address stroke care (STK-1: Venous Thromboembolism (VTE) Prophylaxis, STK-2: Discharged on Antithrombotic Therapy, STK-3: Anticoagulation Therapy for Atrial Fibrillation/Flutter, STK-5: Antithrombotic Therapy By End of Hospital Day 2, STK-6 Discharged on Statin Medication, STK-8: Stroke Education, and STK-10: Assessed for Rehabilitation) that are used in The Joint Commission’s Disease-Specific Care stroke certification programs.

        • 1.14 Numerator

          Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (less than or equal to 180 minutes) of time last known well.

        • 1.15 Denominator

          Acute ischemic stroke patients whose time of arrival is within 2 hours (less than or equal to 120 minutes) of time last known well.

        • Exclusions

          • Less than 18 years of age
          • Length of Stay > 120 days
          • Enrolled in clinical trials related to stroke
          • Admitted for elective carotid intervention
          • Time last known well to arrival in the emergency department greater than 2 hours
          • Documented reason for extending the initiation of IV thrombolytic
          • Documented reason for not initiating IV thrombolytic

        • Most Recent Endorsement Activity
          Endorsed Neurology Project 2015-2016
          Initial Endorsement
          Last Updated
        • Steward
          The Joint Commission
          Steward Organization POC Email
          Steward Organization Copyright

          No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in Joint Commission accreditation, including ORYX® vendors, are required to update their software and associated documentation based on the published manual production timelines.